chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient has a history of multiple sclerosis and angioedema. She received her second Moderna vaccine on 2/7. Two days later, 2/9, she developed upper lip swelling without tongue or airway involvement. No shortness of breath, dyspnea on exertion, chest pain, wheezing or difficulty breathing. She took 100 mg Benadryl without improvement , then dexamethasone 10 mg PO. She was then directed to urgent care where she was given an additional 50 mg benadryl and 10 mg decadron.
In 2020 / received an influenza vaccine / again he lost his ability to walk; This case was reported by a consumer via call center representative and described the occurrence of walking difficulty in a 71-year-old male patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of gait disturbance (received 1st dose in 2019 along with pneumococcal vaccine and an influenza vaccine, refer case US2021071621), Pneumococcal vaccine with an associated reaction of gait disturbance and Influenza vaccine with an associated reaction of gait disturbance.   On an unknown date, the patient received Influenza vaccine Quadrivalent 2020-2021 season. On an unknown date, less than a year after receiving Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced walking difficulty. Rechallenge with Influenza vaccine Quadrivalent 2020-2021 season was positive. On an unknown date, the outcome of the walking difficulty was recovered/resolved.   It was unknown if the reporter considered the walking difficulty to be related to Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were provided as follows: The age at vaccination was not reported but it could be 70 years or 71 years. In 2020, the patient received an Influenza vaccine (name unknown) and again he lost his ability to walk and slowly the ability to walk returned and resolved in about a week. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021071621:Same reporter
This case was reported by a consumer and described the occurrence of rash in a 44-year-old female patient who received ENGERIX B adult. The patient's past medical history included blood pressure high, arthritis and drug allergy (allergy to amoxicillin). Concomitant products included atenolol and diclofenac. In May 2010, the patient received ENGERIX B adult. In May 2011, 1 year after receiving ENGERIX B adult, the patient experienced rash, itching, nasal congestion, wheezing and sinus infection. On an unknown date, the outcome of the rash, itching, nasal congestion, wheezing and sinus infection were not recovered/not resolved. It was unknown if the reporter considered the rash, itching, nasal congestion, wheezing and sinus infection to be related to ENGERIX B adult. Additional information received: Patient reported that after a complete series of ENGERIX-B vaccinations, she began to develop rashes. The patient said that the rash starts every year around the same time as when she was injected in May 2010. There were no events that occurred at time of injection. The patient reports that every year around this time, when the weather gets warmer, she experiences rash that begins on her arms and spreads to her back. The rash is also itchy. The patient reports that she has nasal congestion and wheezing around the same time of year as well.
similar reaction after 2nd dose; freezing and tired; with wheezing that he was experiencing and helped further more when he took the 2nd dose.; similar reaction after 2nd dose; freezing and tired; This spontaneous case was reported by a patient and describes the occurrence of FEELING COLD (similar reaction after 2nd dose; freezing and tired), THERAPEUTIC RESPONSE UNEXPECTED (with wheezing that he was experiencing and helped further more when he took the 2nd dose.) and FATIGUE (similar reaction after 2nd dose; freezing and tired) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020E21A, 025A21A and 065F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING COLD (similar reaction after 2nd dose; freezing and tired), THERAPEUTIC RESPONSE UNEXPECTED (with wheezing that he was experiencing and helped further more when he took the 2nd dose.) and FATIGUE (similar reaction after 2nd dose; freezing and tired). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING COLD (similar reaction after 2nd dose; freezing and tired), THERAPEUTIC RESPONSE UNEXPECTED (with wheezing that he was experiencing and helped further more when he took the 2nd dose.) and FATIGUE (similar reaction after 2nd dose; freezing and tired) outcome was unknown.            Concomitant medications details were not reported by the reporter.   This case was linked to MOD-2021-390907, MOD-2021-390861 (Patient Link).
Local swelling at injection site about 50 cent piece size 10/06/2003.  Next day 10/07/2003, about 13:00 complained of shortness of breath, generalized itching and rash bilateral arm, chest, neck.  Prescribed: Benadryl at employee health.  Complained of 2nd shortness of breath.  Required albuterol rehab, 5 day prednisone 40mg.
Awakened at 6am extremely nauseous, dizzy and weak. in am hour her right arm and leg became limp and her speech was slurred. She could not stand or sit and just toppled over on the bed. Rushed by ambulance to hospital. (note attached)--My mother went into the hospital on 09/27/2002 and was diagnosed with pneumonia and bronchial infection. After 2 weeks i was told by the lung doctor, that it was cleared up, so she was released from the hospital. Her private MD suggested she go to rehab for some physical therapy. She left the hospital on 10/11/2002, and went to rehab. She did great and was very active. While there, with her doctor's permission, they gave her the flu shot on 10/18/2002 and the pneumonia shot on 10/21/2002. On 10/22/2002 she came home, and had a stroke on 10/25/2002. She died in the hospital on 11/15/2002, gasping for breath. Her blood pressure was normal during both her hospital stays and rehab. During her 3 days back home, she was active and fortunately well. What concerns me in that the pneumonia vaccine may have been given too close to the flu vaccine. (3 days). Also, when she went back to the hospital with the stroke, they said she still had some pneumonia. Maybe she shouldn't have been given the vaccine if she still had some pneumonia. Also, at this time her blood sugar went out of control reaching between 300-400, without food. i know my mother was old with several conditions. but everyone sent her home with a clean bill of health and much hope, not to have a stroke after 3 days. I was her caregiver, but she was also very independent. Her mind was still functioning very well until the end. Not being able to speak fluently or walk or eat and having strangers change her really broke her spirit and broke my heart.  We were very close. I loved and needed her very much, and she loved me so much. She didn't want that vaccine, but with her doctor's permission, I encouraged her to take it. That's why these questions are haunting me. I would appreciate someone helping me understand what happened. Was i
Arm soreness began within hours. Arm soreness around injection site continued to get worse over the next 24 hours. On a scale of 1-10, I?d say a 3. Function impaired but not preventing using my arm.  Unable to sleep overnight. Restlessness. Chills occurred overnight and into the next morning. Temperature reading taken at time of a chill event was 99F. Mild headache, lethargy, tiredness, and body soreness. Daily function impaired but not blocked. The vaccine basically kicked my ass. Sore all over, tired, etc.  A slight cough existed as well. Began morning of 9/17.
Dizziness, Headache, NauseaVomiting, pre-existing morning sickness Narrative: Per nursing report: "received her vaccine on 8/3/2021, and started having symptoms of dizziness, headache, nausea, and vomiting, that started within 10 minutes of her receiving her 1st dose. She is 5 months pregnant and states she does have morning sickness through out the day during this pregnancy."
Pt was given a Moderna vaccine #1 and the vaccine was 2 days expired.  This was reported to the provider and to patient. Pt doing ok and was not having any symptoms other than the normal when receiving a vaccine. Pt was advised about incident 2 days after administered.
Patient stated about a week after getting the shot, she started developing what looks like shingles (red with pustule-filled white lesions / rash) going up her arm.  She stated it doesn't itch.
High fever. Dizziness. 5/14 shot. 5/20 fever 104 deg. 5/21 took him to Dr. 5/24 took him to hosp fever and pneumonia. 5/26 Dr said hehas pneumonia in right lung.
her heart beats heavy; she did not lay down back in bed; light headedness/ she experienced dizziness; nausea; This is a spontaneous report from a contactable nurse.  An 80-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number EL9265) via an unspecified route of administration, left arm on 02Feb2021 at a single dose (at the age of 80 years-old) for COVID-19 immunization. The patient's medical history included vertigo, arthritis, anemic, muscle spasms, high cholesterol quadruple vessel bypass graft and patient concomitant medications included as atorvastatin, cyclobenzaprine. On 03Feb2021 during the night patient experienced dizziness, light headedness, nausea, heart rate abnormal, activities of daily living impaired. Patient's normally her heart beats heavy but that was normal to the patient. The patient had already been diagnosed with vertigo prior vaccination. Patient paperwork stated that it was not recommended to receive the second dose, but patient wanted to know if what patient experienced qualified for her not to take it. The patient known second dose was higher than the first dose. There were unknown investigations done. The labs from last time patient went for them, they were concerned patient LDL was very low and the cholesterol was off, this was about a month ago. The outcome of the events dizziness, light headedness and nausea was recovered. The outcome of the remaining events outcome was unknown.  No follow-up attempts are needed. No further information is expected.
Patient stated that 3 hours (7:40 pm)after receiving her vaccine she experience symptoms of: low grade temp of 93.6 (3 digital thermometers and 2 mercury thermometers) light headedness felt unsteady but blood pressure was ok per patient throat started to feel tight -these symptoms lasted for approx.  1/2 hour (8:10 pm) after giving herself an epi-pen injection, which she carries for bee stings -patient stated the next day on 02/19/2021, she took 2 tablets each 25 mg. of benadryl and never experienced the symptoms again from the previous day.
booster; breakthrough cases/ despite being double vaccinated and boosted/ mild symptoms; breakthrough cases/ despite being double vaccinated and boosted/ mild symptoms; This is a spontaneous report received from a contactable reporter (Consumer).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant), outcome "unknown", described as "booster"; DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "breakthrough cases/ despite being double vaccinated and boosted/ mild symptoms". The patient (wife) and her husband had breakthrough cases just before the holidays despite being double vaccinated and boosted. She had relatively mild symptoms. They avoided serious illness due to your vaccine.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200073889 same reporter, product and event; different patients
Shortly after first Moderna injection, while driving home, developed shortness of breath and chest pain, was diagnosed with an MI per the hospital, abnormal EKG and enzymes, currently on ventilator and awaiting surgery for coronary bypass surgery. Hospitalized at the point of this input.
C/o severe sore arm with warmth, redness and swelling. After receiving pneumonia vaccine. Had previous pneumonia vaccine 9/29/99.
patient died after receiving Pfizer; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization. The following information was reported: DEATH (death, medically significant), outcome "fatal", described as "patient died after receiving Pfizer". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. Clinical course: On 10Dec2022, it was reported that a patient started treatment on an unspecified date with Pfizer 2-dose primary series. It was reported that the patient died after receiving Pfizer. No further follow-up was anticipated. On 13Dec2022, the caller stated her friend's husband already reported to Pfizer.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: patient died after receiving Pfizer
Narrative:  103yo male died at his assisted living facility after having a stroke. Pt's son reported that his father was at an ALF and had a stroke a week ago and wasn't eating. "He just dies of old age. He was 103 years old." Pt had received covid vaccines from same facility on 2/20/2021 & 4/19/2021. This death likely is not related to covid vaccines given pt's advanced age & stroke listed as cause of death. ALso great time between date of vaccines and date of death.
Erythema left arm, pt reported Tues evening 10/24 pain arm, stiffness and pain left side body cramping left leg Tues with increased difficulty breathing.
Patient expressed feeling hot and short of breath shortly after receiving the Moderna Vaccine.  Paramedics were called as a precaution, but the patient appeared to be refusing treatment.   She had no visible symptoms other than a manic state.   The paramedics said that she had an elevated heart rate.   The paramedics took her outside for further evaluation.  She later returned to the Pharmacy stating that she did go to the hospital.
Administer expired vaccine to patient, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient, after the manufacture date of expiration) in a 60-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 173 doses. The vial did not undergo any temperature excursions.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up received and included no significant information.
Given DT 6/14/06 for superficial laceration on lower leg. 6/15/06, had acute onset of weakness, dizziness and vomiting. Lab work showed CPK 85 and increased LFT, given 2 liters of fluids with improvement.
The patient developed a rash at the injection site on 1/20/21, after having the vaccine on 1/12/21. She stated that it was itchy and that it was slightly raised. The patient stated the rash has stopped itching some yesterday but was starting to itch again today. She stated that it was not itching severely and she didn't feel as though she needed to "dig" at the location. She had not tried to treat the rash yet.
Patient reported redness and swelling about inch around her injection site. Reported on 5/15. Counseled patient that redness and swelling should have resolved by then. Recommended benadryl and hydrocortisone. If those did not help or resolve to contact doctor.
I had diarrhea; I was a little sick when I got the first vaccine; I wasn't able to go to the bathroom; I have things going on with my organs; This is a spontaneous report from a contactable consumer. A 69-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection; Batch/Lot number was not re-ported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. Medical history included neoplasm malignant (cancer survivor) from an un-known date and unknown if ongoing. The patient's concomitant medications were not reported. The consumer stated I was a little sick when I got the first vaccine, I wasn't able to go to the bathroom, then I had diarrhea. I'm a cancer survivor. I have things going on with my organs. The outcome of the events was unknown.  Information on LOT/BATCH number has been requested.  Follow-up attempts completed. No further information expected.
First dose on 02/14/2021 received 10:15 am. Symptoms started approximately 8 to 10 hours later. I experienced Brain fog, fatigue, weakness generalized malaise, headache,  sore arm . No treatment, symptoms resolved after 4 days.
Muscle soreness; muscle stiffness; This is a spontaneous report from a contactable consumer (patient). A 31-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN 5318), via an unspecified route of administration at the left arm on 26Jan2021 15:00 at single dose for COVID-19 immunization. The patient has no medical history. No allergies to medications, food, or other products. Concomitant medication included oral birth control. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient experienced muscle soreness and muscle stiffness on 26Jan2021 18:00 with outcome of recovering. The patient did not receive any treatment for the events.
Initially, joint pain and fatigue.  Blood pressure became erratic and unstable, ultimately topping out around 210/130.  Irregular heart beat issue also.  Prior to injection BP had been stable on 50 mg Losartan.  It has now been ten weeks since I got the first vaccine dose and I still have pain in shoulders, elbows, log bones in my arms and joints in my hands.  Also in my hips, knees, ankles and lower back.  This occurs primarily at night.  Blood pressure now requires 100 mg Losartan plus 5mg amlodipine to keep it down.   I have been an endurance athlete (ultra marathon kayak racing) but am still experiencing excessive fatigue after even minor exertion.  I'm probably overlooking some variable in this, but can't think of what.  Timing is very suspicious.   Was hospitalized for one day when the blood pressure topped out.
diarrhea; red hard bump the size of a dime on teh side of her arm at the injection site; red hard bump the size of a dime on the side of her arm at the injection site; soreness at the injection site; A spontaneous report was received from a 66 year old female consumer who was participating in the mRNA-1273 Emergency Use Program and experienced soreness at the injection site and later a red hard bump the size of a dime on the side of her arm at the injection site.    The patient's medical history was not provided. No relevant concomitant medications were reported.   On 29 Dec 2020, prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (Batch number not provided) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   On 29 Dec 2020, after receiving the vaccine, the patient experienced soreness at the injection site. On 08 Jan 2021, the patient developed a red hard bump the size of a dime on the side of her arm at the injection site. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, experienced soreness at the injection site and later a red hard bump the size of a dime on the side of her arm at the injection site, were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
seizure x 3;2x  30JAN99;1 x 31JAN99;
Suffered a minor Stroke on 8/6 and then a massive stroke on 8/21.
SWOLLEN FACE; PAIN; SHUT PAIN WAS LIKE SUNBURN; RASH ON FACE; This spontaneous report received from a patient concerned a 73 year elderly female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no known drug allergies and no relevant medical history. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, intramuscular, batch number : unknown expiry: unknown) dose was not reported, 1 total administered on 12-JUN-2021 for prophylactic vaccination.  It was unknown if the patient experienced any adverse reaction following administration of covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient had non-company suspect drug as adalimumab (solution for injection in pre-filled pen, subcutaneous, batch number: 1158967 expiry: unknown) dose, frequency, and therapy dates were not reported for unknown indication. The patient did not receive any concomitant medications. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, intramuscular, batch number: unknown expiry: unknown) dose was not reported, 1 total administered on 15-JAN-2022 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.  On 30-JAN-2022, the patient experienced rash on face. On an unspecified date, the patient experienced swollen face, pain and sunburn (reported as shut pain was like sunburn) (dose number in series 2). Laboratory data included: Lupus anticoagulant (NR: not provided) negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and treatment with adalimumab was withdrawn. The patient was recovering from rash on face, and the outcome of swollen face, pain and sunburn was not reported. This report was non-serious.
Temperature of 102.6°F from 11pm until 5am, then temperatures up and down between 101.5°F , 100.6°F and 99.9°F  Body aches Fatigue Headache